Status:
COMPLETED
Advancing STOP: Self-regulation Therapy for Opioid Addiction and Pain
Lead Sponsor:
University of Colorado, Denver
Conditions:
Opioid-use Disorder
Chronic Pain
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The public health relevance of this proposed project is substantial given the current opioid abuse epidemic as identified by the Centers for Disease Control (CDC). This study finalizes and tests a new...
Eligibility Criteria
Inclusion
- 18-65 years old;
- Willing to adhere to study protocol including treatment sessions and assessments;
- Individuals have a history of co-morbid opioid use disorder and chronic pain;
- Cognitively able to participate and give informed consent.
Exclusion
- Acute or unstable psychotic disorder;
- Psychiatric hospitalization or suicide attempt in the past 3 months
- Patient has been diagnosed with an unstable cardiovascular condition including: myocardial infarction, arrhythmia, or poorly controlled hypertension in the past 3 months
- Lack of verbal and written English fluency
- Over the age of 65 since evidence suggests pain perception alters with age
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT03363243
Start Date
March 1 2018
End Date
June 30 2024
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Denver
Denver, Colorado, United States, 80204